Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Papillary thyroid carcinomas with lung metastases.

Jen-Der Lin1, Tzu-Chieh Chao, Shuo-Chi Chou

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Kweishan County, Taoyuan Hsien, Taiwan, Republic of China. einjd@adm.cgmh.org.tw

Thyroid : Official Journal of the American Thyroid Association
|January 15, 2005
PubMed
Summary

Papillary thyroid carcinoma with lung metastases has a similar prognosis whether diagnosed at initial presentation or later. Prognostic factors include age, gender, tumor size, and thyroglobulin levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the influence of two deep-learning assistance modes on pathologists in cancer identification.

Diagnostic pathology·2026
Same author

Risk factors and outcomes of metastatic poorly differentiated thyroid carcinoma.

World journal of clinical cases·2025
Same author

DNA-PKcs inhibition as a therapeutic approach for differentiated thyroid cancer.

Endocrine-related cancer·2025
Same author

Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer.

Cancers·2025
Same author

Integrated multi-omics analyses of oral squamous cell carcinoma reveal precision patient stratification and personalized treatment strategies.

Cancer letters·2025
Same author

Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma.

Virchows Archiv : an international journal of pathology·2024

Area of Science:

  • Oncology
  • Endocrinology
  • Medical Research

Background:

  • Limited data exists on papillary thyroid carcinoma (PTC) with lung metastases.
  • Understanding presentation, treatment, and prognosis is crucial for patient outcomes.

Purpose of the Study:

  • To analyze the characteristics, treatment outcomes, and prognostic factors of PTC with lung metastases.
  • To compare survival rates between patients with lung-only metastases and those with multiorgan involvement.

Main Methods:

  • Retrospective analysis of 1516 PTC patients treated between 1979-2002.
  • Focus on 102 patients with lung metastases, analyzing demographics, diagnosis timing, and follow-up data.
  • Kaplan-Meier survival analysis was employed.

Related Experiment Videos

Main Results:

  • 27.5% of patients with lung metastases died after a mean follow-up of 8.8 years.
  • 5- and 20-year survival rates for lung metastases were 91.3% and 51.2%, versus 99.0% and 98.0% for no distant metastasis.
  • Age, gender, postoperative thyroglobulin (Tg), and tumor size were significant prognostic factors.

Conclusions:

  • Prognosis for PTC with lung metastases is consistent regardless of diagnosis timing (initial vs. later).
  • No significant survival difference was observed between lung-only metastases and multiorgan metastases.